Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.8%
Wed, 24 Jul 12:18

MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.8%Image source: ipopba/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 6% and is presently trading at Rs 199.3.

Meanwhile, the BSE HEALTHCARE index is at 39,061.4 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 8.8%) and HIKAL CHEMIC (up 3.2%).

Torrent Pharma (down 2.9%) and ASTRAZENECA PHARMA (down 2.2%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 105.5 to Rs 199.3, registering a gain of Rs 93.8 (up 88.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 39,061.4, registering a gain of 45.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 95.9%), Lupin (up 94.1%) and Jubilant Pharmova (up 94.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,000.7 (down 0.5%).

The top losers among the BSE Sensex today are Bajaj Finance (down 2.2%) and Axis Bank (down 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,379.9 (down 0.4%). Axis Bank and Bajaj Finance are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,000.7, registering a gain of 13,615.9 points (up 20.5%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit fell 6.1% YoY to Rs 776 million for the quarter ended March 2024, compared to a profit of Rs 827 million a year ago. Net sales rose 15.2% to Rs 5,600 million during the period as against Rs 4,860 million in January-March 2023.

For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 28.7.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 6%; BSE HEALTHCARE Index Up 0.8%". Click here!